NEOMED-LABS
NEOMED-LABS is a provider of clinical immunology laboratory services for biologics drug development. NEOMED-LABS is an independent, pure player in the immunology field whose team of experts and state of the art BSL2 labs were instrumental in the development, qualification, and validation of more than 30 assays supporting the FDA filing of 10 marketed vaccines whose cumulative sales is around $3bn. Our unrivaled expertise in immunotools engineering and stability testing, as well as our capacity of 200k results per year on our immunochemistry, virology, and bacteriology automated platforms are devoted to personalized services and fast track method validation.
NEOMED-LABS
Social Links:
Industry:
Biotechnology Health Care Life Science
Address:
Laval, Quebec, Canada
Country:
Canada
Website Url:
http://www.neomedlabs.com
Status:
Active
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Domain Not Resolving Mobile Non Scaleable Content Microsoft Azure DNS GoDaddy DNS Google Google Cloud OpenResty
Similar Organizations
Merck
Merck is a pharmaceutical and chemical enterprise that develops prescription drugs and over-the-counter products.
PCI Pharma Services
PCI Pharma Services is a provider of outsourced services to the global pharmaceutical market.
URL Pharma, Inc.
URL Pharma is a pharmaceuticals company specializing in drug research and development services.
Official Site Inspections
http://www.neomedlabs.com
- Host name: redirect.idp365.net
- IP address: 217.19.248.132
- Location: Milton Keynes United Kingdom
- Latitude: 52.0675
- Longitude: -0.7569
- Timezone: Europe/London
- Postal: MK14
More informations about "NEOMED-LABS"
NEOMED-LABS - Crunchbase Company Profile & Funding
NEOMED-LABS is a provider of clinical immunology laboratory services for biologics drug development.See details»
NEOMED-LABS - LinkedIn
OVERVIEW NEOMED-LABS is a leading, independent, pure player in the immunology field whose team of experts and state of the art BSL2 labs were instrumental in the development, …See details»
NEOMED-LABS / Pacific Biomarkers Strengthens its Immunology …
LAVAL, QC, June 6, 2019 – The recently merged NEOMED-LABS / Pacific Biomarkers (NLPBI), a leading immunology centric service provider specialized in assay development and clinical …See details»
NEOMED-LABS / Pacific Biomarkers Strengthens its …
Jun 6, 2019 · Organization Profile. /CNW Telbec/ - The recently merged NEOMED-LABS / Pacific Biomarkers (NLPBI), a leading immunology centric …See details»
Laval, QC, Canada - q2labsolutions.com
Organization incubating health care ventures. Management and Ampersand Capital acquires NEOMED-LABS from NEOMED Institute with the aim to execute a high-growth strategy and …See details»
Neomed-Labs Inc Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Neomed-Labs Inc of Laval, QC. Get the latest business insights from Dun & Bradstreet.See details»
NEOMED-LABS - Contacts, Employees, Board Members, Advisors …
NEOMED-LABS is a provider of clinical immunology laboratory services for biologics drug development.See details»
NEOMED-LABS awarded GCLP Accreditation - Nexelis, a Q² …
Mar 30, 2017 · NEOMED-LABS supports clinical Phase I to IV vaccine development programs of multinational pharma companies, Biotechs and non-for profit organizations. This accreditation …See details»
NEOMED-LABS - Funding, Financials, Valuation & Investors
Nov 19, 2018 · NEOMED-LABS is a provider of clinical immunology laboratory services for biologics drug development.See details»
Ampersand Invests in Management Buyout of Clinical …
Sep 4, 2018 · NEOMED-LABS is a leading provider of clinical immunology laboratory services for biologics drug development, with extensive experience supporting the development of novel …See details»
Ampersand Invests in Management Buyout of Clinical ... - Newswire
Sep 4, 2018 · NEOMED-LABS is a leading provider of clinical immunology laboratory services for biologics drug development, with extensive experience supporting the development of novel …See details»
Ampersand Invests in Management Buyout of Clinical …
Sep 4, 2018 · NEOMED-LABS is a leading provider of clinical immunology laboratory services for biologics drug development, with extensive experience supporting the development of novel …See details»
NEOMED-LABS / Pacific Biomarkers Strengthens its Immunology …
LAVAL, QC, June 6, 2019 /PRNewswire/ - The recently merged NEOMED-LABS / Pacific Biomarkers (NLPBI), a leading immunology centric service provider specialized in assay …See details»
NEOMED-LABS Renews Strategic Agreement with GSK - Newswire
May 31, 2018 · NEOMED-LABS is a spin-out from GSK's Clinical Laboratory Services since April 2015 with a three-year original agreement. Following a successful transition from GSK, …See details»
NEOMED-LABS / Pacific Biomarkers Strengthens its Immunology
LAVAL, QC, June 6, 2019 /PRNewswire/ - The recently merged NEOMED-LABS / Pacific Biomarkers (NLPBI), a leading immunology centric service provider specialized in assay …See details»
NEOMED-LABS, Inc. - Drug pipelines, Patents, Clinical trials
Explore NEOMED-LABS, Inc. with its drug pipeline, therapeutic area, technology platform, 4 clinical trials, 11 news, and 3 literature.See details»
LAVAL, QC, CANADA - Nexelis, a Q² Solutions Company
LAVAL, QC, CANADA. Key Features. Laval is the mothership site of Nexelis with a history of success in developing vaccine technology for a broad array of infectious diseases.See details»
NEOMED to play key role in Quebec’s new life sciences strategy
Much of the earlier stage research once done by big pharma is now done by these companies, including NEOMED Labs, which contract services to multinationals, including GSK and others. …See details»
NEOMED-LABS Renews Strategic Agreement with GSK
NEOMED-LABS is a spin-out from GSK’s Clinical Laboratory Services since April 2015 with a three-year original agreement. Following a successful transition from GSK, NEOMED-LABS …See details»
NEOMED-LABS and Public Health England Announce a Strategic …
Jun 27, 2019 · Laval, Quebec and Porton, United Kingdom, June 27 2019 – NEOMED-LABS and Public Health England’s (PHE) National Infection Service are pleased to announce that they …See details»